Petco Health and Wellness Co. (WOOF)
(Delayed Data from NSDQ)
$1.66 USD
+0.01 (0.61%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $1.66 0.00 (0.00%) 6:32 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Income Statements
Fiscal Year end for Petco Health and Wellness Company, Inc falls in the month of January .
All items in Millions except EPS data.
1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 | |
---|---|---|---|---|---|
Sales | 6,255 | 6,036 | 5,807 | 4,920 | 4,435 |
Cost Of Goods | 3,901 | 3,609 | 3,381 | 2,813 | 2,528 |
Gross Profit | 2,354 | 2,427 | 2,427 | 2,107 | 1,907 |
Selling & Adminstrative & Depr. & Amort Expenses | 3,534 | 2,202 | 2,161 | 1,912 | 1,796 |
Income After Depreciation & Amortization | -1,180 | 226 | 266 | 194 | 111 |
Non-Operating Income | 7 | -12 | 14 | -17 | 0 |
Interest Expense | 151 | 102 | 77 | 219 | 253 |
Pretax Income | -1,324 | 112 | 202 | -42 | -142 |
Income Taxes | -28 | 35 | 53 | -3 | -36 |
Minority Interest | 0 | -1 | -5 | -5 | -8 |
Investment Gains/Losses | 16 | 13 | 11 | 6 | 2 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -1,280 | 90 | 160 | -32 | -104 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -1,280 | 91 | 164 | -26 | -96 |
Depreciation Footnote | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 248 | 424 | 444 | 394 | 327 |
Depreciation & Amortization (Cash Flow) | 1,428 | 199 | 178 | 199 | 216 |
Income After Depreciation & Amortization | -1,180 | 226 | 266 | 194 | 111 |
Earnings Per Share Data | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Average Shares | 267.55 | 265.95 | 265.34 | 210.70 | NA |
Diluted EPS Before Non-Recurring Items | -0.15 | 0.58 | 0.72 | 0.23 | NA |
Diluted Net EPS (GAAP) | -4.78 | 0.34 | 0.62 | -0.13 | -0.07 |
Fiscal Year end for Petco Health and Wellness Company, Inc falls in the month of January .
All items in Millions except EPS data.
1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 | |
---|---|---|---|---|---|
Sales | 1,674.48 | 1,494.17 | 1,530.73 | 1,555.91 | 1,577.96 |
Cost Of Goods | 1,068.13 | 944.17 | 937.73 | 951.43 | 950.68 |
Gross Profit | 606.35 | 550.00 | 593.00 | 604.48 | 627.28 |
SG&A, R&D, and Dept/Amort Expenses | 606.18 | 1,782.13 | 568.97 | 576.87 | 549.72 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.17 | -1,232.13 | 24.03 | 27.61 | 77.56 |
Non-Operating Income | 0.32 | 1.08 | 2.25 | 3.56 | -2.55 |
Interest Expense | 39.66 | 36.56 | 37.49 | 37.20 | 32.88 |
Pretax Income | -39.17 | -1,267.61 | -11.20 | -6.03 | 42.12 |
Income Taxes | -10.44 | -22.90 | 6.73 | -1.01 | 14.55 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 6.16 | 3.57 | 3.33 | 3.13 | 5.16 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -22.57 | -1,241.14 | -14.61 | -1.89 | 32.73 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -22.58 | -1,241.14 | -14.61 | -1.89 | 32.73 |
Earnings Per Share Data | 1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 |
---|---|---|---|---|---|
Average Shares | 268.62 | 267.85 | 267.16 | 266.49 | 266.30 |
Diluted EPS Before Non-Recurring Items | -0.03 | -0.10 | -0.01 | 0.00 | 0.17 |
Diluted Net EPS (GAAP) | -0.09 | -4.63 | -0.05 | -0.01 | 0.13 |